“Tracking Large Variations in My Immune Biomarkers and My Gut Microbiome: Inflammation, Crohn's Disease, and Colon Cancer” IBD Conference Speaker Series.

Slides:



Advertisements
Similar presentations
A Systems Approach to Personalized Medicine Talk and Discussion NASA Ames Mountain View, CA March 28, 2013 Dr. Larry Smarr Director, California Institute.
Advertisements

Reading Out the State of the Body and How it Changes Under Therapy Guest Lecture Pharmacy Informatics 2013 University of California San Diego June 7, 2013.
Large Memory High Performance Computing Enables Comparison Across Human Gut Microbiome of Patients with Autoimmune Diseases and Healthy Subjects XSEDE.
Deep Self - Quantifying the State of Your Body Invited Talk NextMed / MMVR20 San Diego February 21, 2013 Dr. Larry Smarr Director, California Institute.
“Tracking Immune Biomarkers and the Human Gut Microbiome: Inflammation, Crohn's Disease, and Colon Cancer” USC Monthly Seminar Series Physical Sciences.
Exploring Our Inner Universe Using Supercomputers and Gene Sequencers Physics Department Colloquium UC San Diego October 24, 2013 Dr. Larry Smarr Director,
Discussion Janssen La Jolla Research and Development La Jolla, CA
Leveraging Biomedical Big Data: Quantified Self & Beyond Invited Talk FutureMed Singularity University NASA Ames Campus February 5, 2013 Dr. Larry Smarr.
The Microbiome: What’s the immune system got to do with it?
“The Systems Biology Dynamics of the Human Immune System and Gut Microbiome” Invited Talk UCI Systems Biology Seminar Series Irvine, CA October 14, 2013.
“Using Data Analytics to Discover the 100 Trillion Bacteria Living Within Each of Us” Invited Talk New Applications of Computer Analysis to Biomedical.
“Finding the Patterns in the Big Data From Human Microbiome Ecology” Invited Talk Exponential Medicine November 10, 2014 Dr. Larry Smarr Director, California.
“Personalized Medicine, Colorectal Cancer and Gut Bacteria”
The Microbiome and Metagenomics
Correlation Between Bacteria and Inflammatory Bowel Diseases
DAREDEVILS: Prajwal Acharya, Cristina Johnson, Julie David, Jen Masciovecchio, Yen Phan.
“Quantifying Your Superorganism Body Using Big Data Supercomputing” Ken Kennedy Institute Distinguished Lecture Rice University Houston, TX November 12,
“The Quantified Self Movement: The Technologies That Are Revolutionizing Health and Fitness” Panel Discussion MIT Enterprise Forum San Diego UC San Diego.
“Discovering the Other 90% of our Human Superorganism” Remote Video Lecture to The eResearch Australasia Conference 2014 Melbourne, Australia October 28,
“Inflammation, Gut Microbiome, Bacteriophages, and the Initiation of Colorectal Cancer” Seminar Lecture City of Hope Pasadena, CA October 20, 2014 Dr.
My N=1 Experience Pioneer Session: "N=1: Pioneers of Self-Tracking“ Panel at the Genomes, Environment, and Traits Conference Harvard Medical School Cambridge,
“Mapping the Human Gut Microbiome in Health and Disease Using Sequencing, Supercomputing, and Data Analysis” Invited Talk Delivered by Mehrdad Yazdani,
“The Quantified Self: From Idiosyncratic Hobby to an Emerging Growth Industry” Invited Lecture Science & Technology Discovery Series Technology Alliance.
“Measuring the Human Brain-Gut Microbiome-Immune System Dynamics: a Big Data Challenge” Plenary Talk 45 th Annual Meeting of the Behavior Genetics Association.
“The Digital Transformation of Healthcare”
Inflammatory Bowel Disease Francisco A. Sylvester, MD Associate Professor of Pediatrics.
“Big Data and Superorganism Genomics – Microbial Metagenomics Meets Human Genomics” NGS and the Future of Medicine Illumina Headquarters La Jolla, CA February.
H = -Σp i log 2 p i. SCOPI Each one of the many microbial communities has its own structure and ecosystem, depending on the body environment it exists.
“Quantifying The Dynamics of Your Superorganism Body Using Big Data Supercomputing” Distinguished Lecturer Series Computer Science and Engineering.
“The Deeply Quantified Self: A Case Study” Future Technology Keynote Minimally Invasive Surgery Week 2015 Society of Laparoendoscopic Surgeons New York.
“Quantified Health and Disease” Lecture for the Osher Lifetime Learning Institute UCSD Extension Calit2’s Qualcomm Institute, UCSD La Jolla, CA February.
“Using Data Analytics to Discover the 100 Trillion Bacteria Living Within Each of Us” Invited Talk Ayasdi Menlo Park, CA December 5, 2014 Dr. Larry Smarr.
“Toward Novel Human Microbiome Surveillance Diagnostics to Support Public Health” Invited Talk Institute for Public Health University of California San.
“Quantified Self- On Being a Personal Genomic Observatory” Keynote in the “Humans as Genomic Observatories” Meeting Session in the Genomics Standards Consortium.
“The Human Microbiome and the Revolution in Digital Health” The Florida Institute for Human and Machine Cognition Pensacola Evening Lecture Series Pensacola,
“Using Supercomputing & Advanced Analytic Software to Discover Radical Changes in the Human Microbiome in Health and Disease” Invited Remote Presentation.
“Creating a High Performance Cyberinfrastructure to Support Analysis of Illumina Metagenomic Data” DNA Day Department of Computer Science and Engineering.
“Comparative Human Microbiome Analysis” Remote Video Talk to CICESE Big Data, Big Network Workshop Ensenada, Mexico October 10, 2013 Dr. Larry Smarr Director,
The Human Microbiome: PSC, IBD, and the Gut-Liver Axis
“Individual, Consumer-Driven Care of the Future -- Taking Wellness One Step Further” Closing Keynote Address The World Congress 2 nd Annual Leadership.
“Inspired by Carl: Exploring the Microbial Dynamics Within” Invited Talk Looking in the Right Direction: Carl Woese and the New Biology University of Illinois,
“Living in a Microbial World” Global Health Program Council on Foreign Relations New York, NY April 10, 2014 Dr. Larry Smarr Director, California Institute.
“How Studying Astrophysics and Coral Reefs Enabled Me to Become an Empowered, Engaged Patient” Invited Talk FutureMed at the Hotel Del Coronado, CA November.
“Frontiers of Self-Tracking” Plenary Talk Quantified Self Conference 2012 Stanford University September 15, 2012 Dr. Larry Smarr Director, California Institute.
Crohn’s Disease & Mycobacterial Infections Kimberly Persley, MD October 19, 2005.
“Deciphering the Dynamic Coupling of the Human Immune System and the Gut Microbiome” Overview Data-Enabled Life Sciences Research (DELSA) DELSA Workshop.
“Observing the Dynamics of the Human Immune System Coupled to the Microbiome in Health and Disease” CASIS Workshop on Biomedical Research Aboard the ISS.
“Quantifying Your Superorganism Body Using Big Data Supercomputing” ACM International Workshop on Big Data in Life Sciences BigLS 2014 Newport Beach, CA.
“Assay Lab Within Your Body: Biometrics and Biomes” Invited Lecture TSensors Summit La Jolla, CA November 12, 2014 Dr. Larry Smarr Director, California.
“Discovering the Other 90% of our Human Superorganism” Remote Video Lecture to The eResearch Australasia Conference 2014 Melbourne, Australia October 28,
“Quantifying the Time Progression of the Interaction of the Human Immune System with the Gut Microbiome” Research Council Presentation UC San Diego Health.
Lecture Science & Entertainment Exchange National Academy of Sciences Los Angeles June 13, 2013 Dr. Larry Smarr Director, California Institute for Telecommunications.
“Know Thyself: Quantifying Your Human Body and Its One Hundred Trillion Microbes” Understanding Cultures and Addressing Disparities in Society: Degrees.
“Using Genetic Sequencing to Unravel the Dynamics of Your Superorganism Body” Weekly Bioinformatics Seminar Series UC San Diego La Jolla, CA October 17,
“Adding Consumer-Generated and Microbiome Data to the Electronic Medical Record” Using Big Data to Advance Healthcare Panel National Health Policy Conference.
“Quantifying Your Dynamic Human Body (Including Its Microbiome), Will Move Us From a Sickcare System to a Healthcare System” Invited Presentation Microbiology.
Keynote Presentation Cavendish Global Health Impact Forum
“Connecting Body Time Series to Macro Body Changes”
“Analyzing the Human Gut Microbiome Dynamics in Health and Disease Using Supercomputers and Supernetworks” Invited Presentation ESnet CrossConnects Bioinformatics.
“Linking Phenotype Changes to Internal/External Longitudinal Time Series in a Single Human” Invited Presentation at EMBC ‘16 38th International Conference.
What’s All the Fuss About the Microbiome?
“Machine Learning in Healthcare Diagnostics”
Briefing for Dell Analytics Team Calit2’s Qualcomm Institute
Invited Presentation Machine Learning in Healthcare
H = -Σpi log2 pi.
Metagenomics and Personalized Medicine
J. -C. Lagier, F. Armougom, M. Million, P. Hugon, I. Pagnier, C
Pathogenic Escherichia coli in inflammatory bowel diseases
Metagenomics and Personalized Medicine
Toward Accurate and Quantitative Comparative Metagenomics
Presentation transcript:

“Tracking Large Variations in My Immune Biomarkers and My Gut Microbiome: Inflammation, Crohn's Disease, and Colon Cancer” IBD Conference Speaker Series Icahn School of Medicine at Mount Sinai New York City, NY October 29, 2013 Dr. Larry Smarr Director, California Institute for Telecommunications and Information Technology Harry E. Gruber Professor, Dept. of Computer Science and Engineering Jacobs School of Engineering, UCSD 1

From Quantified Self to National-Scale Biomedical Research Projects My Anonymized Human Genome is Available for Download The Quantified Human Initiative is an effort to combine our natural curiosity about self with new research paradigms. Rich datasets of two individuals, Drs. Smarr and Snyder, serve as 21 st century personal data prototypes.

By Measuring the State of My Body and “Tuning” It Using Nutrition and Exercise, I Became Healthier 2000 Age Age Age I Arrived in La Jolla in 2000 After 20 Years in the Midwest and Decided to Move Against the Obesity Trend I Reversed My Body’s Decline By Quantifying and Altering Nutrition and Exercise

From One to a Billion Data Points Defining Me: The Exponential Rise in Body Data in Just One Decade! Billion: My Full DNA, MRI/CT Images Million: My DNA SNPs, Zeo, FitBit Hundred: My Blood Variables One: My Weight Weight Blood Variables SNPs Microbial Genome Improving Body Discovering Disease Each is a Personal Time Series And Compared Across Population

Visualizing Time Series of 150 LS Blood and Stool Variables, Each Over 5-10 Years Calit2 64 megapixel VROOM

I Discovered I Had Episodic Chronic Inflammation by Tracking Complex Reactive Protein In My Blood Samples Normal Range <1 mg/L Normal 27x Upper Limit Antibiotics CRP is a Generic Measure of Inflammation in the Blood

By Adding Stool Samples, I Discovered I Had High Levels of the Protein Lactoferrin Shed from Neutrophils Normal Range <7.3 µg/mL 124x Upper Limit Antibiotics Lactoferrin is a Protein Shed from Neutrophils - An Antibacterial that Sequesters Iron Typical Lactoferrin Value for Active IBD

Four Immune Biomarkers Over Time Compared with Four Signs/Symptoms Here Immune biomarkers are normalized 0 to 1, with 1 being the highest value in five years Source: Photo of Calit2 64-megapixel VROOM

Colonoscopy Images Show Persistent Inflamed Pseudopolyps in 6 inches of Sigmoid Colon Dec 2010 Jan 2012 “Inflammatory polyp versus inflamed fold in the distal sigmoid colon and apthous ulcers in the rectum, consistent with active Crohn’s colitis.” William J. Sandborn, MD UCSD Jan 3, 2012

Descending Colon Sigmoid Colon Threading Iliac Arteries Major Kink Confirming the Colonic Crohn’s Hypothesis: Finding the “Smoking Gun” with MRI Imaging I Obtained the MRI Slices From UCSD Medical Services and Converted to Interactive 3D Working With Calit2 Staff & DeskVOX Software Transverse Colon Liver Small Intestine Diseased Sigmoid Colon Cross Section MRI Jan 2012

MRE Reveals Inflammation in 6 Inches of Sigmoid Colon Thickness 15cm – 5x Normal Thickness “Long segment wall thickening in the proximal and mid portions of the sigmoid colon, extending over a segment of approximately 16 cm, with suggestion of intramural sinus tracts. Edema in the sigmoid mesentery and engorgement of the regional vasa recta.” – MRI report Jan 2012 Clinical MRI Slice Program DeskVOX 3D Image Crohn's disease affects the thickness of the intestinal wall. Having Crohn's disease that affects your colon increases your risk of colon cancer.

Why Did I Have an Autoimmune Disease like IBD? Despite decades of research, the etiology of Crohn's disease remains unknown. Its pathogenesis may involve a complex interplay between host genetics, immune dysfunction, and microbial or environmental factors. --The Role of Microbes in Crohn's Disease Paul B. Eckburg & David A. Relman Clin Infect Dis. 44: (2007) I Have Been Quantifying All Three

Quantifying My Gut Microbiome

First, Analyze the Dynamics of My Microbiome Ecology- 85% of the Species Can Not Be Cultured Inclusion of the Microbiome Will Radically Change Medicine 99% of Your DNA Genes Are in Microbe Cells Not Human Cells Your Body Has 10 Times As Many Microbe Cells As Human Cells

J. Craig Venter Institute Performed Metagenomic Sequencing on Seven of My Stool Samples Sequencing on Illumina HiSeq 2000 at JCVI Generates 100bp Reads Run Takes ~14 Days My 7 Samples Produced –190.2 Gbp of Data DNA Extraction Uses –Standard MOBio Powersoil DNA Extraction JCVI Lab Manager, Genomic Medicine –Manolito Torralba IRB PI Karen Nelson –President JCVI Illumina HiSeq 2000 at JCVI Manolito Torralba, JCVI Karen Nelson, JCVI

Additional Phenotypes Added from NIH HMP For Comparative Analysis 5 Ileal Crohn’s Patients, 3 Points in Time 2 Ulcerative Colitis Patients, 6 Points in Time “Healthy” Individuals Download Raw Reads ~100M Per Person Source: Jerry Sheehan, Calit2 Weizhong Li, Sitao Wu, CRBS, UCSD Total of 5 Billion Reads IBD Patients 35 Subjects 1 Point in Time Larry Smarr 7 Points in Time

We Created a Reference Database Of Known Gut Genomes NCBI April 2013 –2471 Complete Draft Bacteria & Archaea Genomes –2399 Complete Virus Genomes –26 Complete Fungi Genomes –309 HMP Eukaryote Reference Genomes Total 10,741 genomes, ~30 GB of sequences Now to Align Our 5 Billion Reads Against the Reference Database Source: Weizhong Li, Sitao Wu, CRBS, UCSD

Computational NextGen Sequencing Pipeline: From “Big Equations” to “Big Data” Computing PI: (Weizhong Li, CRBS, UCSD): NIH R01HG ( , $1.1M)

We Used SDSC’s Gordon Data-Intensive Supercomputer to Analyze a Wide Range of Gut Microbiomes ~180,000 Core-Hrs on Gordon –KEGG function annotation: 90,000 hrs –Mapping: 36,000 hrs –Used 16 Cores/Node and up to 50 nodes –Duplicates removal: 18,000 hrs –Assembly: 18,000 hrs –Other: 18,000 hrs Gordon RAM Required –64GB RAM for Reference DB –192GB RAM for Assembly Gordon Disk Required –Ultra-Fast Disk Holds Ref DB for All Nodes –8TB for All Subjects Enabled by a Grant of Time on Gordon from SDSC Director Mike Norman

Using Scalable Visualization Allows Comparison of the Relative Abundance of 200 Microbe Species Calit2 VROOM-FuturePatient Expedition Comparing 3 LS Time Snapshots (Left) with Healthy, Crohn’s, UC (Right Top to Bottom)

Lessons from Ecological Dynamics I: Gut Microbiome Has Multiple Relatively Stable Equilibria “The Application of Ecological Theory Toward an Understanding of the Human Microbiome,” Elizabeth Costello, Keaton Stagaman, Les Dethlefsen, Brendan Bohannan, David Relman Science 336, (2012)

Comparison of 35 Healthy to 15 CD and 6 UC Gut Microbiomes at the Phyla Level Explosion of Proteobacteria Collapse of Bacteroidetes Expansion of Actinobacteria

Lessons From Ecological Dynamics II: Invasive Species Dominate After Major Species Destroyed ”In many areas following these burns invasive species are able to establish themselves, crowding out native species.” invasive species Source: Ponderosa Pine Fire Ecology

Almost All Abundant Species (≥1%) in Healthy Subjects Are Severely Depleted in Larry’s Gut Microbiome

Top 20 Most Abundant Microbial Species In LS vs. Average Healthy Subject 152x 765x 148x 849x 483x 220x 201x 522x 169x Number Above LS Blue Bar is Multiple of LS Abundance Compared to Average Healthy Abundance Per Species Source: Sequencing JCVI; Analysis Weizhong Li, UCSD LS December 28, 2011 Stool Sample

Rare Firmicutes Bloom in Colon Disappearing After Antibiotic/Immunosuppressant Therapy Firmicutes Families LS Time 2 Healthy Average LS Time 1 Parvimonas spp. Therapy

Lessons From Ecological Dynamics III: From Equilibrium to Chaos In addition to chaos, other forms of complex dynamics, such as regular oscillations & quasiperiodic oscillations, are preeminent features of many biological systems. - From “Biological Chaos and Complex Dynamics” David A. Vasseur Oxford Bibliographies Online

The Dramatic Bloom of Enterobacteriaceae bacterium 9_2_54FAA 21,000x LS5  LS6 1,000x This Microbe is a Proteobacteria Targeted by the NIH HMP

Can Microbial Metagenomics Diagnose Disease States? From SNPs Associated with CD Mutation in Interleukin-23 Receptor Gene—80% Higher Risk of Pro-inflammatory Immune Response 2009

Phyla Gut Microbial Abundance Without Viruses: LS, Crohn’s, UC, and Healthy Subjects Crohn’s Ulcerative Colitis Healthy LS Toward Noninvasive Microbial Ecology Diagnostics Source: Weizhong Li, Sitao Wu, CRBS, UCSD

Clustering Using Supervised Classification Algorithms: SLiME: Synthetic Learning in Microbial Ecology Papa, et al. PLOS ONE (2012)

Is the Gut Microbial Ecology Different in Crohn’s Disease Subtypes? Ben Willing, GASTROENTEROLOGY 2010;139:1844 –1854

It Appears That Metabolomics Can Differentiate Ileum vs. Colon Inflammation in Crohn’s Disease blue N= Ileum (ICD) red N= Colon (CCD) green N= Healthy Jansson, et al. PLOS ONE, July 2009 | Volume 4 | Issue 7 | e6386

Quantifying My Human Genome

I Compared my 23andme SNPs With the 163 Known SNPs Associated with IBD The width of the bar is proportional to the variance explained by that locus Bars are connected together if they are identified as being associated with both phenotypes Loci are labelled if they explain more than 1% of the total variance explained by all loci “Host–microbe interactions have shaped the genetic architecture of inflammatory bowel disease,” Jostins, et al. Nature 491, (2012)

I Found I Had One of the Earliest Known SNPs Associated with Crohn’s Disease From SNPs Associated with CD Polymorphism in Interleukin-23 Receptor Gene — 80% Higher Risk of Pro-inflammatory Immune Response rs NOD2 IRGM ATG16L1

There Is Likely a Correlation Between CD SNPs and Where and When the Disease Manifests Me-Male CD Onset At 60-Years Old Female CD Onset At 20-Years Old NOD2 (1) rs Il-23R rs Subject with Ileal Crohn’s Subject with Colon Crohn’s Source: Larry Smarr and 23andme

I Also Had an Increased Risk for Ulcerative Colitis, But a SNP that is Also Associated with Colonic CD I Have a 33% Increased Risk for Ulcerative Colitis HLA-DRA (rs ) I Have the Same Level of HLA-DRA Increased Risk as Another Male Who Has Had Ulcerative Colitis for 20 Years “Our results suggest that at least for the SNPs investigated [including HLA-DRA], colonic CD and UC have common genetic basis.” -Waterman, et al., IBD 17, (2011)

Now Working with 23andme Comparing 163 Known IBD SNPs with 23andme SNP Chip Currently 300,000 23andme Members –Growing Rapidly to One Million IBD Affects ~1/300 Americans –Implies ~3000 IBD Subjects –Detailed IBD Survey to Members for Phenotyping Enables Internal GWAS Also Working with Crohnology (Sean Ahrens) –Encouraging His >5000 Crohn’s Members to Use 23andme –Combine SNPs with Detailed Phenotyping and Drug Impacts

Quantifying My Human Immune System

I Have Been Quantifying the Time Behavior of the Coupled Immune System and Microbiome “Advances in our understanding of the interplay between components of the innate and adaptive arms of the immune system will be central to future progress.” -Judy H. Cho, The Genetics and Immunopathogenesis of Inflammatory Bowel Disease, Nature Reviews Immunology (2008)

Fine Time Resolution Sampling Reveals Unexpected Oscillations of Innate and Adaptive Immune System Normal Time Points of Metagenomic Sequencing of LS Stool Samples Therapy: 1 Month Antibiotics +2 Month Prednisone Innate Immune System Normal Adaptive Immune System LS Data from Yourfuturehealth.com Lysozyme & SIgA From Stool Tests

LS Cultured Bacterial Abundance Reveals Oscillatory Microbiome Ecology Time Points of Metagenomic Sequencing of LS Stool Samples LS Data from Yourfuturehealth.com

Time Series Reveals Autoimmune Dynamics of Gut Microbiome by Phyla Therapy Six Metagenomic Time Samples Over 16 Months

Fusobacteria Are Found To Be More Abundant In Colonrectal Carcinoma (CRC) Tissue et al.

Class Fusobacteria Is Enriched in Human Colon Cancer Tumors Kostic, A. D., et al. “Genomic analysis identifies association of Fusobacterium with colorectal carcinoma”, v. 22: 292–298 (2012) “…the relative abundance of Fusobacterium was highly enriched in the population of tumor versus normal samples…”

The Bacterial Driver-Passenger Model for Colorectal Cancer Initiation Is Fusobacterium nucleatum a “Driver” or a “Passenger” Tjalsma, et al. Nature Reviews Microbiology v. 10, (2012) “Early detection of Colorectal Cancer (CRC) is one of the greatest challenges in the battle against this disease & the establishment of a CRC-associated microbiome risk profile could aid in the early identification of individuals who are at high risk and require strict surveillance.”

“Arthur et al. provide evidence that inflammation alters the intestinal microbiota by favouring the proliferation of genotoxic commensals, and that the Escherichia coli genotoxin colibactin promotes colorectal cancer (CRC).” Christina Tobin Kåhrström Associate Editor, Nature Reviews Microbiology

Inflammation Enables Anaerobic Respiration Which Leads to Phylum-Level Shifts in the Gut Microbiome Sebastian E. Winter, Christopher A. Lopez & Andreas J. Bäumler, EMBO reports VOL 14, p (2013)

E. coli/Shigella Phylogenetic Tree Miquel, et al. PLOS ONE, v. 5, p (2010) Does Intestinal Inflammation Select for Pathogenic Strains That Can Induce Further Damage? “Adherent-invasive E. coli (AIEC) are isolated more commonly from the intestinal mucosa of individuals with Crohn’s disease than from healthy controls.” “Thus, the mechanisms leading to dysbiosis might also select for intestinal colonization with more harmful members of the Enterobacteriaceae* —such as AIEC— thereby exacerbating inflammation and interfering with its resolution.” Sebastian E. Winter, et al., EMBO reports VOL 14, p (2013) *Family Containing E. coli AIEC LF82

Chronic Inflammation Can Accumulate Cancer-Causing Bacteria in the Human Gut Escherichia coli Strain NC101

Phylogenetic Tree 778 Ecoli strains =6x our 2012 Set D A B1 B2 E S Deep Metagenomic Sequencing Enables Strain Analysis

We Divided the 778 E. coli Strains into 40 Groups, Each of Which Had 80% Identical Genes LS00 1 LS00 2 LS00 3 Median CD Median UC Median HE Group 0: D Group 2: E Group 3: A, B1 Group 4: B1 Group 5: B2 Group 7: B2 Group 9: S Group 18,19,20: S Group 26: B2 LF82 NC101

Next Step: Time Series of Metagenomic Gut Microbiomes and Immune Variables in an N=100 Clinic Trial Goal: Understand The Coupled Human Immune-Microbiome Dynamics In the Presence of Human Genetic Predispositions

The Role of Bacteriophage in IBD

What Caused the Dramatic Drop in My Inflammation Before Taking Antibiotics? Normal Range <1 mg/L Normal 27x Upper Limit Antibiotics CRP is a Generic Measure of Inflammation in the Blood

Radical Shift in Relative Abundance After Therapy

LS001 Viral Abundance is Similar to Some UC Patients, But Different Families Virus Families

LS001 Relative Abundance of Viruses Among All Virus, Bacteria, Archaea, Eukaryota Abundance >0.1% Out of 493 Viral Reference Species Podoviridae SP6-Like Siphoviridae All 3 SP6-Like Vanish in LS002/003

My Viral Load is Mainly SP-6 Like

Reduction in E. coli Over Time With Major Shifts in Strain Abundance Strains >0.5% Included Therapy

Log Reduction in LS Viral Relative Abundance Over Time

Thanks to Our Great Team! UCSD Metagenomics Team Weizhong Li Sitao Wu Future Patient Team Jerry Sheehan Tom DeFanti Kevin Patrick Jurgen Schulze Andrew Prudhomme Philip Weber Fred Raab Joe Keefe Ernesto Ramirez JCVI Team Karen Nelson Shibu Yooseph Manolito Torralba SDSC Team Michael Norman Mahidhar Tatineni Robert Sinkovits